乌鸦传媒

Second-line T-DXd best option in patients with and without intracranial activity, experts says

Also in TTHealthWatch: time from approval to reimbursement for new drugs

News, features, and commentary about cancer-related issues

News, features, and commentary about cancer-related issues

Recommendations for short-interval follow-up or biopsy likely a factor

In cancer survivorship, we must address patients' psychological wellness

Meta-analysis shows ICIs also improved pCR rates in HR-positive/HER2-negative disease

But benefit in modeling study accompanied by more false-positive biopsy recommendations

News, features, and commentary about cancer-related issues

Health news and commentary gathered by 乌鸦传媒 staff

A study's 30-year follow-up data provided no new insights into which patients benefit from RT

Researchers suggest unfavorable risk-benefit ratio "disqualifies" it as a staging tool

News, features, and commentary about cancer-related issues

Colorectal cancer screening accounted for 64% of the total amount